EUVIMEDEUVIMED entdecken
Open Access

Quetiapine Significantly Improves the Effectiveness of Radiotherapy in Combating Hepatocellular Carcinoma Progression in a Hep3B Xenograft Mouse Model

Jr-DI Yang, Yu-Chang Liu, Hsiao-Chia Wang, Fei-Ting Hsu, Tsai Lan Liao, Meng-Chu Huang, Jiann-Hwa Chen

In Vivo · 2024

DOI: 10.21873/invivo.13542 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Vivo, 2024. Verfasst von Jr-DI Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Urology, Department of Surgery, National Yang-Ming Chiao Tung University Hospital, Yilan, Taiwan, R.O.C. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Xenograft Model Antitumor Assays, Quetiapine Fumarate. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: In hepatocellular carcinoma (HCC) treatment, radiotherapy (RT) stands as a pivotal approach, yet the emergence of radioresistance poses a formidable challenge. This study aimed to explore the potential synergy between quetiapine and RT for HCC treatment. MATERIALS AND METHODS: A Hep3B xenograft mouse model was used, the investigation tracked tumor progression, safety parameters, and molecular mechanisms. RESULTS: The findings revealed a synergistic anti-HCC effect when quetiapine was coupled with RT that prolonged tumor growth time and a significantly higher growth inhibition rate compared to the control group. Safety assessments indicated minimal pathological changes, suggesting potential of quetiapine in mitigating RT-induced alterations in liver and kidney functions. Mechanistically, the combination suppressed metastasis and angiogenesis-related proteins, while triggering the activation of apoptosis-related proteins via targeting Epidermal growth factor receptor (EGFR)-mediated signaling. CONCLUSION: The potential of the quetiapine and RT combination is emphasized, offering enhanced anti-HCC efficacy, a safety profile, and positioning quetiapine as a radiosensitizer for HCC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsXenograft Model Antitumor AssaysQuetiapine FumarateAnimalsMiceHumansCell Line, TumorDisease Models, AnimalApoptosisDisease ProgressionCell ProliferationMale

Stichwörter der Autor:innen

EGFRQuetiapinehepatocellular carcinomaradiosensitizerradiotherapy

Substanzen

Quetiapine Fumarate

Autor:innen und Institutionen

  • Division of Urology, Department of Surgery, National Yang-Ming Chiao Tung University Hospital, Yilan, Taiwan, R.O.C.
  • Department of Radiation Oncology, Chang Bing Show Chwan Memorial Hospital, Changhua, Taiwan, R.O.C.
  • Department of Radiation Oncology, Show Chwan Memorial Hospital, Changhua, Taiwan, R.O.C.
  • Department of Medical Imaging and Radiological Sciences, Central Taiwan University of Science and Technology, Taichung, Taiwan, R.O.C.
  • Department of Emergency Medicine, Cathay General Hospital, Taipei, Taiwan, R.O.C.
  • School of Medicine, Fu Jen Catholic University, Taipei, Taiwan, R.O.C.

Zitieren

APA

Yang, J. D., Liu, Y. C., Wang, H. C., Hsu, F. T., Liao, T. L., Huang, M. C., & Chen, J. H. (2024). Quetiapine Significantly Improves the Effectiveness of Radiotherapy in Combating Hepatocellular Carcinoma Progression in a Hep3B Xenograft Mouse Model. In Vivo. https://doi.org/10.21873/invivo.13542

Vancouver

Yang JD, Liu YC, Wang HC, Hsu FT, Liao TL, Huang MC, et al. Quetiapine Significantly Improves the Effectiveness of Radiotherapy in Combating Hepatocellular Carcinoma Progression in a Hep3B Xenograft Mouse Model. In Vivo. 2024. doi:10.21873/invivo.13542

BibTeX
@article{Yang2024,
  author = {Yang, Jr-DI and Liu, Yu-Chang and Wang, Hsiao-Chia and Hsu, Fei-Ting and Liao, Tsai Lan and Huang, Meng-Chu and Chen, Jiann-Hwa},
  title = {Quetiapine Significantly Improves the Effectiveness of Radiotherapy in Combating Hepatocellular Carcinoma Progression in a Hep3B Xenograft Mouse Model},
  journal = {In Vivo},
  year = {2024},
  doi = {10.21873/invivo.13542}
}
Kostenlos starten →